초음파 창상 괴사조직제거 기기 시장 규모, 점유율, 동향 분석 : 제품별, 적응증별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Ultrasound Wound Debridement Devices Market Size, Share & Trends Analysis By Product, By Indication, By End Use, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,590,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 10,034,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,922,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

초음파 창상 괴사조직제거 기기 시장 : 개요

세계의 초음파 창상 괴사조직제거 기기 시장 규모는 2024년에 7억 4,349만 달러로 추계되며, 2025-2030년에 CAGR 7.05%로 성장하며, 2030년에는 11억 1,775만 달러에 달할 것으로 예측됩니다. 초음파 창상 괴사조직제거 기기에 대한 수요는 만성 상처의 부담 증가와 전 세계 수술 건수 증가로 인해 증가하고 있습니다.

사우디아라비아의 King Abdullah University of Science and Technology와 콜롬비아의 Leprosy Control Program이 2024년 8월에 발표한 연구에 따르면 만성 상처는 전 세계에서 4,000만 명에게 영향을 미칩니다고 합니다. 만성 상처의 부담이 크기 때문에 예측 기간 중 초음파 창상 괴사조직제거 기기에 대한 수요가 증가할 것으로 예측됩니다. 초음파 상처 드레드맨은 만성 및 급성 상처를 세척하는 효과적이고 부드러운 방법입니다.

이 방법은 손이 잘 닿지 않는 부위도 큰 수술 없이도 큰 수술 없이도 출혈을 제거할 수 있습니다. 당뇨병성 족부궤양, 욕창, 하지궤양과 같은 만성 상처와 화상, 수술 후 상처, 외상 등의 급성 상처 치료에 많이 사용됩니다. Aurealis Therapeutics가 2024년 4월 발표한 자료에 따르면 당뇨병 환자가 당뇨병성 족부궤양(DFU)에 걸릴 평생 위험은 19-34%에 달할 전망입니다. 위험은 19-34%입니다. 전 세계에서 당뇨병 환자의 DFU 유병률은 약 6.3%로 추정됩니다. 이처럼 당뇨병과 같은 만성질환의 유병률 증가는 DFU 및 욕창과 같은 만성 상처 치료를 지원하는 제품에 대한 수요를 촉진하여 초음파 창상 괴사조직제거 기기 시장을 촉진하고 있습니다.

아래 그래프는 인도, 중국, 태국, 태국, 호주, 한국 등 아시아태평양의 DFU 부담 증가를 보여주고 있으며, DFU 부담이 가장 큰 국가는 중국으로 예상되며, 초음파 창상 괴사조직제거 기기 산업 기업이 아시아태평양에서 제품 범위를 확장하고 큰 매출 점유율을 확보할 수 있는 잠재적 기회를 보여주고 있습니다.

Soring GmbH, Mavera Medical, Esacrom 등 여러 기업이 DFU를 포함한 만성 상처 치료용 제품을 제공합니다. 이와 같이 상처 부담 증가는 초음파 창상 괴사조직제거 기기 산업을 견인할 것으로 예측됩니다.

"솔링 UAW는 DFU 치료에 있으며, 데브리드만 직후뿐만 아니라 치료 기간 중에도 박테리아의 양을 크게 감소시킬 수 있었습니다. " "라고 독일 스달츠 클리닉 노르드하우젠의 상처 관리 책임자 Mario GieBler는 말합니다.

또한 초음파 창상 괴사조직제거 기기에 초점을 맞춘 임상시험 및 연구 활동 증가는 향후 수년간 시장 성장을 지원할 것으로 예측됩니다.

목차

제1장 분석 방법·범위

제2장 개요

제3장 초음파 창상 괴사조직제거 기기 시장 : 변동 요인·경향·범위

• 시장 연관 전망
  • 모시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
  • 시장 기회의 분석
  • 시장이 해결해야 할 과제 분석
• 초음파 창상 괴사조직제거 기기 시장 : 분석 툴
  • 업계 분석 : Porter의 산업 분석
  • PESTEL 분석

제4장 초음파 창상 괴사조직제거 기기 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 초음파 창상 괴사조직제거 기기 시장 : 제품별 변동 분석
• 초음파 창상 괴사조직제거 기기 시장 : 시장 규모 예측과 동향 분석, 제품별(2018-2030년)
• 시스템
• 액세서리/소모품

제5장 초음파 창상 괴사조직제거 기기 시장 : 적응증별 추정·동향 분석

• 부문 대시보드
• 초음파 창상 괴사조직제거 기기 시장 : 적응증별 변동 분석
• 초음파 창상 괴사조직제거 기기 시장 : 시장 규모 예측과 동향 분석, 적응증별(2018-2030년)
• 급성 창상
• 만성 창상

제6장 초음파 창상 괴사조직제거 기기 시장 : 최종 용도별 추정·동향 분석

• 부문 대시보드
• 초음파 창상 괴사조직제거 기기 시장 : 최종 용도별 변동 분석
• 초음파 창상 괴사조직제거 기기 시장 : 시장 규모 예측과 동향 분석, 최종 용도별(2018-2030년)
• 병원
  • 병원 : 시장의 추산·예측(2018-2030년)
• 수술실
  • 수술실 : 시장의 추산·예측(2018-2030년)
• 전문 클리닉(창상관리 클리닉)
  • 전문 클리닉(창상관리 클리닉) : 시장의 추산·예측(2018-2030년)
• 재택 의료
  • 재택 의료 : 시장의 추산·예측(2018-2030년)
• 기타
  • 기타 : 시장의 추산·예측(2018-2030년)

제7장 초음파 창상 괴사조직제거 기기 시장 : 지역별 추정·동향 분석

• 지역별 대시보드
• 시장 규모 예측과 동향 분석(2018-2030년)
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 인도
  • 중국
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 시장 참여 기업 분류
• 주요 기업의 개요
  • Mavera Medical
  • Esacrom
  • Bioventus(Misonix Inc)
  • SANUWAVE Health, Inc.
  • Bioevopeak Co., Ltd.
  • Arobella Medical LLC
  • Soring GmbH
  • Alliqua Biomedical
  • Shenzhen Acare International Industrial Co., Ltd.
  • GUNZE LIMITED
• 히트맵 분석/기업 시장 현황 분석
• 기업별 시장 점유율 예측 분석(2024년)
• 기타 주요 기업의 리스트

KSA

영문 목차

영문목차

Ultrasound Wound Debridement Devices Market Summary

The global ultrasound wound debridement devices market size was estimated at USD 743.49 million in 2024, and is projected to reach USD 1,117.75 million by 2030, growing at a CAGR of 7.05% from 2025 to 2030. The demand for ultrasound wound debridement devices is rising owing to the increasing burden of chronic wounds and the rising number of surgical cases worldwide.

According to a study published by the King Abdullah University of Science and Technology, Saudi Arabia, and the Leprosy Control Program, Colombia, in August 2024, chronic wounds affect 40 million individuals worldwide. The high burden of chronic wounds is anticipated to drive the demand for ultrasound wound debridement devices over the forecast period. Ultrasonic wound debridement is an effective and gentle method for cleansing chronic and acute wounds.

This technique allows for the debridement of even hard-to-reach areas without the need for extensive surgery. It is commonly used to treat chronic wounds, such as diabetic foot ulcers, pressure ulcers, and leg ulcers, as well as acute wounds such as burns, postoperative wounds, and trauma-related injuries. As the incidence of these types of wounds continues to rise, the demand for ultrasonic wound debridement devices is expected to grow significantly. According to data published by Aurealis Therapeutics in April 2024, individuals with diabetes face a 19-34% lifetime risk of developing a diabetic foot ulcer (DFU). Globally, the prevalence of DFUs among people with diabetes is estimated at approximately 6.3%. Thus, the increasing prevalence of chronic diseases like diabetes is driving demand for products that aid in treating chronic wounds, such as DFUs and pressure ulcers, boosting the ultrasonic wound debridement devices market.

The graphical representation below demonstrates the growing burden of DFUs in several Asia Pacific countries, such as India, China, Thailand, Australia, and South Korea. The highest burden is anticipated to be in China, which represents potential opportunities for ultrasound wound debridement device industry players to expand their product reach in the Asia Pacific region to capture a significant revenue share.

Several companies, such as Soring GmbH, Mavera Medical, and Esacrom, offer products for treating chronic wounds, including DFUs. Thus, the increasing burden of wounds is anticipated to drive the ultrasound wound debridement devices industry.

"The Soring UAW was able to significantly reduce the bacterial load in the treatment of DFU, not only right after debridement but also during the entire treatment period." Said Mario GieBler, Head of Wound Management, Sudharz Clinic Nordhausen, Germany

Moreover, the increasing number of clinical trials and research activities focusing on ultrasound wound debridement devices is anticipated to support the market growth in the coming years.

Global Ultrasound Wound Debridement Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global ultrasound wound debridement devices market report based on product, indication, end use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
• Systems
• Accessories/Consumables
• Indication Outlook (Revenue, USD Million, 2018 - 2030)
• Chronic Wounds
  • Leg Ulcers
  • Diabetic Foot Ulcers (DFU)
  • Pressure Ulcers
  • Other Chronic Wounds
• Acute Wounds
  • Surgical Wounds
  • Plastic and Reconstructive Surgery
  • Neurosurgery
  • Gastrointestinal and Affiliated Organ Surgery
  • Urological Surgery
  • General Surgery
  • Orthopedic Surgery
  • Others
  • Split Skin Graft Preparation
  • Burns
  • Trauma Wounds
• End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Hospitals
• Operating Rooms
• Specialty Clinics (Wound care clinics)
• Home Healthcare
• Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Indication
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Ultrasound Wound Debridement Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing burden of chronic wounds
    • 3.2.1.2. Advancements in ultrasound technology
    • 3.2.1.3. Rising number of surgical procedures
    • 3.2.1.4. Increasing number of road accidents and trauma injuries
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of ultrasound wound debridement devices
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Growing number of clinical trials
    • 3.2.3.2. Increasing research activities
    • 3.2.3.3. Launches of novel products
    • 3.2.3.4. Rising geriatric population
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Shortage of healthcare professionals
• 3.3. Ultrasound Wound Debridement Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Ultrasound Wound Debridement Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Ultrasound Wound Debridement Devices Market Product Movement Analysis
• 4.3. Global Ultrasound Wound Debridement Devices Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Systems
  • 4.4.1. Systems market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Accessories/Consumables
  • 4.5.1. Accessories/consumables market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Ultrasound Wound Debridement Devices Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Ultrasound Wound Debridement Devices Market Indication Movement Analysis
• 5.3. Global Ultrasound Wound Debridement Devices Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
• 5.4. Acute Wounds
  • 5.4.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.1.1. Surgical Wounds
      • 5.4.1.1.1. Surgical wounds market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.1.2. Plastic and Reconstructive Surgery
        • 5.4.1.1.2.1. Plastic and reconstructive surgery market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.1.3. Neurosurgery
        • 5.4.1.1.3.1. Neurosurgery market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.1.4. Gastrointestinal and Affiliated Organ Surgery
        • 5.4.1.1.4.1. Gastrointestinal and affiliated organ surgery market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.1.5. Urological Surgery
        • 5.4.1.1.5.1. Urological surgery market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.1.6. General Surgery
        • 5.4.1.1.6.1. General surgery market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.1.7. Orthopedic surgery
        • 5.4.1.1.7.1. Orthopedic surgery market estimates and forecast 2018 to 2030 (USD Million)
      • 5.4.1.1.8. Others
        • 5.4.1.1.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.1.2. Split Skin Graft Preparation
      • 5.4.1.2.1. Split skin graft preparation market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.1.3. Burns
      • 5.4.1.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.1.4. Trauma Wounds
      • 5.4.1.4.1. Trauma wounds market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Chronic Wounds
  • 5.5.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.1. Diabetic foot ulcers
      • 5.5.1.1.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.2. Pressure ulcers
      • 5.5.1.2.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.3. Leg ulcers
      • 5.5.1.3.1. Leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.1.4. Others chronic wounds
      • 5.5.1.4.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Ultrasound Wound Debridement Devices: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Ultrasound Wound Debridement Devices Market End-Use Movement Analysis
• 6.3. Global Ultrasound Wound Debridement Devices Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Operating Rooms
  • 6.5.1. Operating rooms market estimates and forecast 2018 to 2030 (USD Million)
• 6.6. Specialty Clinics (Wound Care Clinics)
  • 6.6.1. Specialty clinics (wound care clinics) market estimates and forecast 2018 to 2030 (USD Million)
• 6.7. Home healthcare
  • 6.7.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Ultrasound Wound Debridement Devices Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 7.3.4. Mexico
    • 7.3.4.1. Key country dynamics
    • 7.3.4.2. Competitive scenario
    • 7.3.4.3. Regulatory framework
    • 7.3.4.4. Reimbursement scenario
    • 7.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Competitive scenario
    • 7.4.1.3. Regulatory framework
    • 7.4.1.4. Reimbursement scenario
    • 7.4.1.5. UK market estimates and forecasts, 2018 - 2030
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. Germany market estimates and forecasts, 2018 - 2030
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. France market estimates and forecasts, 2018 - 2030
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. Italy market estimates and forecasts, 2018 - 2030
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Spain market estimates and forecasts, 2018 - 2030
  • 7.4.6. Denmark
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Norway market estimates and forecasts, 2018 - 2030
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement scenario
    • 7.5.1.5. Japan market estimates and forecasts, 2018 - 2030
  • 7.5.2. India
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. India market estimates and forecasts, 2018 - 2030
  • 7.5.3. China
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. China market estimates and forecasts, 2018 - 2030
  • 7.5.4. South Korea
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. Australia market estimates and forecasts, 2018 - 2030
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement scenario
    • 7.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
  • 7.6.2. Argentina
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. UAE market estimates and forecasts, 2018 - 2030
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Mavera Medical
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Esacrom
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Bioventus (Misonix Inc)
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. SANUWAVE Health, Inc.
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Bioevopeak Co., Ltd.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Arobella Medical LLC
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Soring GmbH
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Alliqua Biomedical
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Shenzhen Acare International Industrial Co., Ltd.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. GUNZE LIMITED
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
• 8.3. Heat Map Analysis/ Company Market Position Analysis
• 8.4. Estimated Company Market Share Analysis, 2024
• 8.5. List of Other Key Market Players

관련자료